VEGFA and hepatocellular carcinoma: Scartozzi and coworkers demonstrated that VEGF rs2010963, VEGFR rs4604006, and BCLC stage served as predictors of overall survival and progression-free survival for HCC patients treated with sorafenib in Italy.